Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Serotonergic system, cognition, and BPSD in Alzheimer’s disease
Saikat Chakraborty, Jack C. Lennon, Sridhar A. Malkaram, et al.
Neuroscience Letters (2019) Vol. 704, pp. 36-44
Open Access | Times Cited: 97

Showing 26-50 of 97 citing articles:

Psychedelics as Novel Therapeutics in Alzheimer’s Disease: Rationale and Potential Mechanisms
Albert Garcia‐Romeu, Sean Darcy, Hillary Jackson, et al.
Current topics in behavioral neurosciences (2021), pp. 287-317
Closed Access | Times Cited: 25
Development and crystallography-aided SAR studies of multifunctional BuChE inhibitors and 5-HT6R antagonists with β-amyloid anti-aggregation properties
Tomasz Wichur, Justyna Godyń, Izabella Góral, et al.
European Journal of Medicinal Chemistry (2021) Vol. 225, pp. 113792-113792
Open Access | Times Cited: 24
Effect of masupirdine (SUVN‐502) on cognition in patients with moderate Alzheimer's disease: A randomized, double‐blind, phase 2, proof‐of‐concept study
Ramakrishna Nirogi, John R. Ieni, Vinod Kumar Goyal, et al.
Alzheimer s & Dementia Translational Research & Clinical Interventions (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 18
Mitochondrial Interaction with Serotonin in Neurobiology and Its Implication in Alzheimer’s Disease
Jing Tian, Eric Y. Du, Lan Guo
Journal of Alzheimer s Disease Reports (2023) Vol. 7, Iss. 1, pp. 1165-1177
Open Access | Times Cited: 9
Structural and functional remodeling of neural networks in β-amyloid driven hippocampal hyperactivity
Jinquan Li, Yanjun Liu, Chuhui Yin, et al.
Ageing Research Reviews (2024) Vol. 101, pp. 102468-102468
Closed Access | Times Cited: 3
Potential beneficial effects of masupirdine (SUVN‐502) on agitation/aggression and psychosis in patients with moderate Alzheimer's disease: Exploratory post hoc analyses
Ramakrishna Nirogi, Pradeep Jayarajan, Vijay Benade, et al.
International Journal of Geriatric Psychiatry (2022) Vol. 37, Iss. 10
Open Access | Times Cited: 14
A review of frequently used Kampo prescriptions. Part 3. Yokukansan
Hideaki Yamaguchi, Tetsuhiro Yoshino, Hiroaki Oizumi, et al.
Traditional & Kampo Medicine (2023) Vol. 10, Iss. 3, pp. 197-223
Open Access | Times Cited: 9
Anxiety and Alzheimer’s disease pathogenesis: focus on 5-HT and CRF systems in 3xTg-AD and TgF344-AD animal models
Nicole C. Reyna, Benjamin J. Clark, Derek A. Hamilton, et al.
Frontiers in Aging Neuroscience (2023) Vol. 15
Open Access | Times Cited: 8
Discovery of 1-(phenylsulfonyl)-1H-indole-based multifunctional ligands targeting cholinesterases and 5-HT6 receptor with anti-aggregation properties against amyloid-beta and tau
Tomasz Wichur, Anna Pasieka, Justyna Godyń, et al.
European Journal of Medicinal Chemistry (2021) Vol. 225, pp. 113783-113783
Open Access | Times Cited: 19
Future Directions in Molecular Imaging of Neurodegenerative Disorders
Henryk Barthel, Victor L. Villemagne, Alexander Drzezga
Journal of Nuclear Medicine (2022) Vol. 63, Iss. Supplement 1, pp. 68S-74S
Open Access | Times Cited: 13
Beyond memory impairment: the complex phenotypic landscape of Alzheimer’s disease
Stathis Argyriou, John F. Fullard, Josh M. Krivinko, et al.
Trends in Molecular Medicine (2024) Vol. 30, Iss. 8, pp. 713-722
Closed Access | Times Cited: 2
Neurobiological alteration in agitation in Alzheimer’s disease and possible interventions
Jagadeesh S. Rao, María Alejandra Tangarife, Ram Mukunda
Frontiers in Psychiatry (2024) Vol. 15
Open Access | Times Cited: 2
Serotonin deficiency from constitutive SKN-1 activation drives pathogen apathy
Tripti Nair, Brandy Weathers, Nicole L. Stuhr, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 2
Serotonin-2B receptor (5-HT2BR) expression and binding in the brain of APPswe/PS1dE9 transgenic mice and in Alzheimer’s disease brain tissue
M Anzalone, Sarmad A. Karam, Sanne R. R. Briting, et al.
Neuroscience Letters (2024) Vol. 844, pp. 138013-138013
Closed Access | Times Cited: 2
SARS-CoV-2 propagation to the TPH2-positive neurons in the ventral tegmental area induces cell death via GSK3β-dependent accumulation of phosphorylated tau
Motoki Imai, Fumitaka Kawakami, Takayuki Uematsu, et al.
PLoS ONE (2024) Vol. 19, Iss. 10, pp. e0312834-e0312834
Open Access | Times Cited: 2
Neurologic and Immunologic Complications of COVID-19: Potential Long-Term Risk Factors for Alzheimer’s Disease
Jack C. Lennon
Journal of Alzheimer s Disease Reports (2020) Vol. 4, Iss. 1, pp. 217-221
Open Access | Times Cited: 18
Tetrahydrobiopterin Improves Recognition Memory in the Triple-Transgenic Mouse Model of Alzheimer’s Disease, Without Altering Amyloid-β and Tau Pathologies
Hortense Fanet, Marine Tournissac, Manon Leclerc, et al.
Journal of Alzheimer s Disease (2020) Vol. 79, Iss. 2, pp. 709-727
Open Access | Times Cited: 17
Behavioral psychological symptoms of dementia and functional connectivity changes: a network-based study
Laura Serra, Michela Bruschini, Carlotta Di Domenico, et al.
Neurobiology of Aging (2020) Vol. 94, pp. 196-206
Open Access | Times Cited: 15
Biological and Pharmacological Characterization of Ascorbic Acid and Nicotinamide Chitosan Nanoparticles against Insulin-Resistance-Induced Cognitive Defects: A Comparative Study
Hend Abd-Allah, Maha Nasr, Omar A. Ahmed‐Farid, et al.
ACS Omega (2021) Vol. 6, Iss. 5, pp. 3587-3601
Open Access | Times Cited: 14
Alzheimer’s Disease and Alzheimer’s Disease-Related Dementias in African Americans: Focus on Caregivers
Jonathan Kopel, Ujala Sehar, Moumita Choudhury, et al.
Healthcare (2023) Vol. 11, Iss. 6, pp. 868-868
Open Access | Times Cited: 5
Exercise to prevent the negative effects of sleep deprivation: A systematic review and meta-analysis
Y. X. Zhao, Boya Huang, Yang Yu, et al.
Neuroscience & Biobehavioral Reviews (2023) Vol. 155, pp. 105433-105433
Closed Access | Times Cited: 5
Effects of olfactory stimulation on cognitive function and behavior problems in older adults with dementia: A systematic literature review
Hye-gyeong Cha, Sisook Kim, Min-Sook Seo, et al.
Geriatric Nursing (2021) Vol. 42, Iss. 5, pp. 1210-1217
Closed Access | Times Cited: 12
Behavioral and Cognitive Response to Selective Serotonin Reuptake Inhibitors in Frontotemporal Lobar Degeneration: A Systematic Review and Meta-analysis
Maheen Nisar, Zohaib Jawed Abubaker, Muhammad Abdullah Nizam, et al.
Clinical Neuropharmacology (2021) Vol. 44, Iss. 5, pp. 175-183
Closed Access | Times Cited: 12
Inhibition of Astrocytic Histamine N-Methyltransferase as a Possible Target for the Treatment of Alzheimer’s Disease
Cecilia Flores‐Clemente, María Inés Nicolás‐Vázquez, Elvia Mera Jiménez, et al.
Biomolecules (2021) Vol. 11, Iss. 10, pp. 1408-1408
Open Access | Times Cited: 12
The influence path of caregivers’ positive aspects, expressed emotion and coping style on behavioral and psychological symptoms of dementia
Shuang Zhang, Xiumei Ying, Shuyan Fang, et al.
Geriatric Nursing (2022) Vol. 44, pp. 143-150
Closed Access | Times Cited: 8

Scroll to top